Literature DB >> 11100021

Medication and medical service utilization for acne 1995-1998.

R S Stern1.   

Abstract

BACKGROUND: Acne occurs in most persons sometime during adolescence or early adulthood and is a frequent reason for visits to dermatologists and for prescription drug therapy.
OBJECTIVE: The purpose of this study was to analyze changes in the utilization of physician services and medications for the treatment of acne.
METHODS: An analysis was performed of data from two US federal surveys of outpatient physician services and prescribing for the years 1980 to 1997 and two commercial sources of drug prescription data for 1996 to 1998. From these data, I estimated visits for acne and drugs prescribed during these visits.
RESULTS: Visits for women principally for acne are about 80% more frequent than those for men. Each year 5 million prescriptions for oral antibiotics and 1.4 million prescriptions for isotretinoin are dispensed for the treatment of acne.
CONCLUSION: Substantial health care resources are devoted to the treatment of acne, with women particularly likely to continue to frequently utilize these services after 19 years of age.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11100021     DOI: 10.1067/mjd.2000.110901

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  10 in total

1.  Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern?

Authors:  Laurent Azoulay; Driss Oraichi; Anick Bérard
Journal:  Eur J Clin Pharmacol       Date:  2006-06-22       Impact factor: 2.953

2.  Isotretinoin use and the risk of inflammatory bowel disease: a case-control study.

Authors:  Seth D Crockett; Carol Q Porter; Christopher F Martin; Robert S Sandler; Michael D Kappelman
Journal:  Am J Gastroenterol       Date:  2010-03-30       Impact factor: 10.864

3.  In vitro antibacterial activity of NB-003 against Propionibacterium acnes.

Authors:  J Pannu; A McCarthy; A Martin; T Hamouda; S Ciotti; L Ma; J Sutcliffe; J R Baker
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

4.  Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.

Authors:  Whitney P Bowe; Jennifer C Filip; Joseph M DiRienzo; Alla Volgina; David J Margolis
Journal:  J Drugs Dermatol       Date:  2006-10       Impact factor: 2.114

5.  Can we ensure the safe use of known human teratogens? Introduction of generic isotretinoin in the US as an example.

Authors:  Margaret A Honein; Cynthia A Moore; J David Erickson
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

6.  Understanding the burden of adult female acne.

Authors:  Emil A Tanghetti; Ariane K Kawata; Selena R Daniels; Karen Yeomans; Caroline T Burk; Valerie D Callender
Journal:  J Clin Aesthet Dermatol       Date:  2014-02

7.  Racial differences in clinical characteristics, perceptions and behaviors, and psychosocial impact of adult female acne.

Authors:  Valerie D Callender; Andrew F Alexis; Selena R Daniels; Ariane K Kawata; Caroline T Burk; Teresa K Wilcox; Susan C Taylor
Journal:  J Clin Aesthet Dermatol       Date:  2014-07

Review 8.  What is the best approach to reducing birth defects associated with isotretinoin?

Authors:  Lorien Abroms; Edward Maibach; Katherine Lyon-Daniel; Steven R Feldman
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069

Review 9.  Prospects of Phage Application in the Treatment of Acne Caused by Propionibacterium acnes.

Authors:  Ewa Jończyk-Matysiak; Beata Weber-Dąbrowska; Maciej Żaczek; Ryszard Międzybrodzki; Sławomir Letkiewicz; Marzanna Łusiak-Szelchowska; Andrzej Górski
Journal:  Front Microbiol       Date:  2017-02-08       Impact factor: 5.640

Review 10.  Role of Metformin in the Management of Polycystic Ovarian Syndrome-Associated Acne: A Systematic Review.

Authors:  Humaira Shamim; Marie Jean; Muaaz Umair; Pratyusha Muddaloor; Michelle Farinango; Akhil Ansary; Amulya Dakka; Zahra Nazir; Chantelle T White; Ahmad B Habbal; Lubna Mohammed
Journal:  Cureus       Date:  2022-08-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.